Michael Kelly

Michael Kelly

Director/Miembro de la Junta en ARS PHARMACEUTICALS, INC. .

Fortuna: 426 944 $ al 31/07/2026

61 años
Health Technology
Consumer Services

Perfil

Mr. Michael Kelly is an Independent Director at ARS Pharmaceuticals, Inc. He is on the Board of Directors at ARS Pharmaceuticals Operations, Inc. and ARS Pharmaceuticals, Inc. Mr. Kelly was previously employed as a President, Chief Executive Officer & Director by NervGen Pharma Corp., a President-US Operations by Adapt Pharma, Inc., a President by Covis Pharmaceuticals, Inc., a Senior Vice President-Sales & Marketing by Jazz Pharmaceuticals Plc, a Senior Vice President & General Manager by Azur Pharma, Inc., a Vice President-Commercial Operations by Guilford Pharmaceuticals, Inc., a Member by Azur Pharma Ltd., and a Vice President-Sales and Marketing by Viropharma, Inc. He received his undergraduate degree from The College of New Jersey and an MBA from Rider University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
24/06/2026 83.225 ( 0,08 % ) 426 944 $ 31/07/2026

Cargos activos de Michael Kelly

EmpresasCargoInicio
ARS PHARMACEUTICALS, INC. Director/Miembro de la Junta 01/05/2019
Director/Miembro de la Junta 01/05/2019

Antiguos cargos conocidos de Michael Kelly.

EmpresasCargoFin
NERVGEN PHARMA CORP. Director Ejecutivo 17/07/2025
Director de Operaciones 01/06/2019
Director Ejecutivo 01/03/2016
Corporate Officer/Principal 27/01/2012
Corporate Officer/Principal 01/01/2012
Ver el detalle de la experiencia de Michael Kelly.

Formación de Michael Kelly.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

60

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Viropharma, Inc.